Zilactin Baby Teething Swabs
This article was originally published in The Tan Sheet
Executive SummaryPrint ads for disposable, pre-medicated swabs are slated to run in July/August issue of American Baby, August-October issues of First Year of Life, Zila Consumer Pharmaceuticals says. Ad campaign, designed by Scottsdale, Ariz.-based L&B, also includes 15-second cable TV spot, mailings to pediatricians, dentists. Sold in boxes of eight for $4.99, the individually wrapped teething swabs contain 10% benzocaine for pain relief with a "special ingredient that produces a cooling sensation on babies' sore gums," Zila notes. Swabs come in "soothing grape flavor" and contain no saccharin, dyes or alcohol. Reaching select stores now, swabs soon will hit food, drug and mass shelves nationwide...
You may also be interested in...
The Conservative Party's victory in the UK general election means the Brexit withdrawal deal will be able to pass. The UK will leave the EU by 31 January and enter a transition period during which medicines regulation will remain broadly unchanged.
Japanese companies agree to discontinue regenerative cell therapy pact after high-profile Phase II failure, but SanBio will move ahead with development and Dainippon will hold onto ex-partner stake for now.
Strides has set a sales target of $200-400m for Stelis’s generic injectables business in two to four years as part of its plan to reach $800m in total revenues in four years. Meanwhile, Stelis’s Rh-teriparatide for osteoporosis and sodium hyaluronate for osteoarthritis await Phase III incremental studies in the US.